MET Price Prediction Next Week
Analysis and Insights
Technical Analysis:
MetLife (MET) is currently trading at $82.36 as of the latest data. Based on the Fibonacci levels, the stock is approaching its first resistance level at $82.98, with a pivot point at $80.67. The Relative Strength Index (RSI) for MET is at 50.86, indicating a neutral position, while the MACD shows a slight bearish signal with a value of -0.37.
News Impact:
Recent news indicates that MET has underperformed compared to its peers, but analysts maintain a "Strong Buy" rating with a mean price target of $96.69, suggesting potential upside. However, the stock has faced challenges due to weaker-than-expected earnings in certain segments and broader market concerns about recession and tariffs.
Price Prediction:
Given the current technical indicators and news sentiment, MET is expected to face resistance at $83.00. If it breaks above this level, the next target could be $84.41. However, if it fails to break out, the stock may dip to $78.36.
Recommendation:
Based on the analysis, it is recommended to sell MET at the resistance level of $83.00 and consider buying on a dip to $78.36.
MET Similar Chart Price Prediction
The price of MET is predicted to go up 1.29%, based on the high correlation periods with PRU. The similarity of these two price pattern on the periods is 95.38%.
MET
PRU
Up: 1.29%Similarity: 95.38%
MET Revenue Forecast
MET EPS Forecast
MET FAQs
What is MET revenue forecast for next quarter？
What is MET eps forecast for next quarter？
MET VS S&P500
MetLife's leading market positions in various international markets (particularly Asia and Latin America) provide opportunities for growth.
MetLife's strategy has reduced exposure to riskier products like variable annuities with minimum guarantees and has increased investments in segments with steadier cash flows like the group benefits business.
The company will be a net beneficiary of rising interest rates in the long run as it can reinvest its maturing fixed-income securities at a higher yield.
MET Analyst's Forecast
Elyse Greenspan
Wells Fargo
Buy
2025-02-19
Price Target
$92 → $97
Upside
+16.77%
Wells Fargo raised the firm's price target on MetLife to $97 from $92 and keeps an Overweight rating on the shares. The firm updated estimates in the life insurance group post the Q4 reports. Wells left the Q4 earnings favoring the more defensive names within the life sector. Its top life idea is Unum Group (UNM).
Ryan Krueger
Keefe, Bruyette & Woods
Buy
2025-02-12
Price Target
$100 → $98
Upside
+18.46%
Jack Matten
BMO Capital
Hold
2025-01-23
Price Target
$97
Upside
+11.8%
